Abiopharma

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

ResMed Inc. Daily Stock Update

AGL Stockholders Who Suffered Significant Financial Loss are Urged to Contact Robbins LLP for Information About Leading the Securities Class Action

AIM ImmunoTech Announces Changes to Key Dates and Terms Related to Announced Rights Offering

Profound Medical Announces Upcoming Investor Events

New Form SCHEDULE 13D/A - Anika Therapeutics, Inc. <b>Filed:</b> 2026-01-27 <b>AccNo:</b> 0000902664-26-000511 <b>Size:</b> 8 KB

Westlake - Westlake Chemical Partners LP Announces Fourth Quarter 2025 Distribution

BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26

Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences

Gilead - Gilead Sciences to Release Fourth Quarter & Full Year 2025 Financial Results on Tuesday, February 10, 2026

Aytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026

SmartVest - Electromed, Inc. to Report Q2 Fiscal 2026 Financial Results on February 10, 2026

Vivani Medical, Inc. Announces Closing of Common Stock Offering